Trademarkia Logo

Canada

C$
Visumix
SEARCHED

on 30 Oct 2024

Last Applicant/ Owned by

Lusante Inc. Corporation number: 1123349-1

7167 Yonge StreetMarkham

ONTARIO

CA

L3T0E1

Serial Number

2083087 filed on 8th Feb 2021

Visumix

Trademark usage description

visumix is a general formulation designed for overall ocular health. it contains all ingredients of areds ii formula, which have been proved to halt Read More

Classification Information


Class [005]
Visumix is a general formulation designed for overall ocular health. It contains all ingredients of AREDS II formula, which have been proved to halt ARMD. It also includes a variety of premium herbal antioxidants, which could protect the eye from sunlight damage and other internal/external insults; thus, extending its usage among the young and even healthy (but at risk) population. Visumix is particularly good at preventing cataracts and macular phototoxic damage from the ambient UV light. Besides, the array of natural antioxidants within the product performs just well at maintaining the overall body and cardiovascular health, an other generation of Visomix is specifically developed to improve microvascular health in retinal vascular disorders such as diabetic retinopathy. It contains collagen, which is a fundamental component of vessel walls, and might be beneficial in relieving or reversing microvascular injuries. The product also includes a variety of potent antioxidant agents that are expected to help retina endure oxidative stress from conditions such as diabetic retinopathy. In addition, it contains beta-carotene and lutein to extend its support to the stressed retinal cells


Classification kind code

11

Class [009]
Electrical, scientific and teaching apparatus and software


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

2083087

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 30th Oct 2024
Search Recorded
Submitted for opposition 20
on 30th Oct 2024
Examiner's First Report
Submitted for opposition 287
on 28th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 8th Feb 2021
Filed
Submitted for opposition 1
on 8th Feb 2021
Created
Submitted for opposition 31
on 8th Feb 2021
Formalized